Zobrazeno 1 - 10
of 39
pro vyhledávání: '"Yong Qian Jia"'
Publikováno v:
Frontiers in Public Health, Vol 11 (2023)
BackgroundAlthough previous studies have identified that both physical activity and sleep problems are independently associated with decreased risk of cognitive function. However, the joint association of physical activity and sleep duration with cog
Externí odkaz:
https://doaj.org/article/d775e20aa6314779bea13e7d5ffd41aa
Autor:
Yuan-Kai Shi, Xiao-Nan Hong, Jian-Liang Yang, Wei Xu, Hui-Qiang Huang, Xiu-Bin Xiao, Jun Zhu, Dao-Bin Zhou, Xiao-Hong Han, Jian-Qiu Wu, Ming-Zhi Zhang, Jie Jin, Xiao-Yan Ke, Wei Li, De-Pei Wu, Shen-Miao Yang, Xin Du, Yong-Qian Jia, Ai-Chun Liu, Dai-Hong Liu, Zhi-Xiang Shen, Lian-Sheng Zhang, Leonard James, Edward Hellriegel, Peng Lyu
Publikováno v:
Chinese Medical Journal, Vol 134, Iss 11, Pp 1299-1309 (2021)
Abstract. Background:. Bendamustine was approved in China on May 26th, 2019 by the National Medical Product Administration for the treatment of indolent B-cell non-Hodgkin lymphoma (NHL). The current study was the registration trial and the first rep
Externí odkaz:
https://doaj.org/article/2e136575615e46fc9bd3c8c49fd5d2b5
Autor:
Shuai-Ge, Gong, Fu-Jue, Wang, Shuo-Ting, Wang, Qin, Zheng, Xiao, Shuai, Hong-Bing, Ma, Li, Zhang, Xin-Chuan, Chen, Yu, Wu, Yong-Qian, Jia
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 29(4)
To compare the efficacy and safety of different doses of daunorubicin combined with a standard dose of cytarabine as induction chemotherapy in newly diagnosed primary acute myeloid leukemia (AML) patients.The clinical data and outcome were retrospect
Autor:
Qian-Qing, Shen, Jie, Gao, Huan, Tao, Shuo-Ting, Wang, Fu-Jue, Wang, Ying-Ying, Chen, Xue, Zhang, Yong-Qian, Jia
Publikováno v:
Am J Blood Res
Introduction: The inflammatory and immune cells have an important impact on Hodgkin lymphoma (HL). The derived neutrophil-lymphocyte ratio (dNLR) has been confirmed to have a similar prognostic value as the neutrophil-lymphocyte ratio (NLR) in many k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::df9ac16cf2e2221914a44133c00080f8
https://europepmc.org/articles/PMC8010605/
https://europepmc.org/articles/PMC8010605/
Publikováno v:
International Journal of Pharmaceutics. 592:120058
Graft-versus-host disease (GVHD) is a frequent complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT). The application of mesenchymal stromal cells (MSCs) to treat GVHD patients refractory to initial steroid treatment h
Publikováno v:
Archives of Pathology & Laboratory Medicine. Jan2012, Vol. 136 Issue 1, p84-89. 6p.
Autor:
Xiao-Gong, Liang, Wen-Tong, Meng, Lian-Jie, Hu, Lin, Li, Hongyun, Xing, Gan, Xie, An-Qiong, Wang, Yong-Qian, Jia
Publikováno v:
Journal of cellular biochemistry. 118(9)
Central nervous system lymphoma (CNSL) remains a diagnostical and therapeutical challenge. MiRNAs post-transcriptionally regulate expression of targeted mRNAs through binding to their 3' UTR to inhibit their translation or promote their degradation.
Publikováno v:
Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition. 46(6)
Construction and identification of recombinant adenovirus vector with human/mouse interferon (IFN-gamma) and effectively transfection into human umbilical cord mesenchymal stem cells (HUMSCs).IFN-gamma gene of human/mouse were amplified from the plas
Autor:
Jing-jing, Li, Qian, Niu, Di-jiao, Tang, Neng-gang, Jiang, Yong-mei, Jin, Jun, Su, Yong-qian, Jia
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 34(11)
To investigate the ratio of Th17 cells and CD4⁺CD25⁺Foxp3⁺ regulatory T (Treg) cells in peripheral blood from patients with multiple myeloma (MM) and explore its pathological effects.70 MM patients were divided into three groups: newly diagnose
Autor:
Li-Xia, Du, Yong-Qian, Jia, Wen-Tong, Meng, Fang-Fang, Shi, Xu-Shu, Zhong, Ling-Ling, Ma, Jin, Yuan, Ji-Sha, Zeng
Publikováno v:
Zhongguo shi yan xue ye xue za zhi. 21(5)
The purpose of this study was to investigate the effects of Celecoxib on the proliferation of the FLT3-ITD positive and negative acute myeloid leukemia cells and its mechanism. The proliferation inhibition effect of Celecoxib with different doses on